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Abstract
Aims-To detect the presence of
Epstein-Barr virus (EBV) in cases of
vulval carcinoma in Chinese patients
living in Hong Kong.
Methods-Formalin fixed, paraffin wax
embedded blocks from eight cases of
vulval carcinoma and six age matched
controls of non-neoplastic vulval tissue
were analysed for the presence of EBV
DNA using the polymerase chain reac-
tion (PCR).
Results-EBV DNA was detected in only
one of the eight cases of vulval carci-
noma cases while it was detected in four
out ofthe six control cases.
Conclusions-There is no demonstrable
association between EBV and vulval
carcinoma. Detection of EBV in non-
neoplastic vulval epithelium highlights
its ubiquitous presence in the lower
female genital tract.
(9 Clin Pathol 1993;46:849-851)
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The aetiological role of viruses in carcinoma
of the lower female genital tract has been the
focus of much research. The association
between human papilloma virus (HPV) and
cervical neoplasia is well known, although
definitive proof of the causal role for this virus
is still inconclusive.' Moreover, HPV has also
been detected in vulval squamous cell carci-
noma.2 The role of synergistic carcinogenic
factors such as two or more viruses interact-
ing at different stages of carcinogenesis has
been considered.3
Epstein Barr Virus (EBV) is an oncogenic
herpes virus associated with certain B cell
lymphomas in humans and also with epithe-
lial tumours such as nasopharyngeal carci-
noma.4 EBV has also been found to replicate
in cervical epithelium, and its possible role in
the development of cervical carcinoma has
been raised.5 The association between EBV
and vulval carcinoma, however, has not been
studied.
Methods
Eight cases of vulval carcinoma and six age
matched control specimens of non-neoplastic
vulval tissue were selected from the files of
the Department of Pathology, University of
Hong Kong. The age of the eight patients
with vulval carcinoma ranged from 65 to 80
(mean 69 9). The age matched control group
of patients were all Chinese and aged 70 or
more. The histological slides were reviewed
and the diagnosis confirmed. The tissue
samples were then obtained from archival,
formalin fixed, paraffin wax embedded
blocks. Only tumour tissue or vulval epithe-
lium in the control group was used for poly-
merase chain reaction (PCR) analysis. This
was confirmed by histological examination of
the sections adjacent to those used for DNA
analysis.
For PCR analysis, two sections 16 pm
thick were cut from each sample and
dewaxed. The genomic DNA was extracted
using proteinase K.
The oligonucleotide primers used for
amplification ofEBV spanned a region of 122
base pairs within the first internal repeat
(IRI) of EBV DNA from base 1399 to 1520.
The oligonucleotide reporter probe spans the
intervening region within the first internal
repeat (IR1) from base 1424 to 1439 (table).
Amplification for EBV DNA was carried
out using the GeneAmp DNA amplification
reagent kit with cloned Taq DNA polymerase
(Perkin Elmer Cetus) using conditions
reported before.6
The amplified products were analysed by
gel electrophoresis in 4% NuSieve 3 in 1
agarose gel (FMC), followed by ethidium
bromide staining.
The specificity of the amplified EBV DNA
product was confirmed by Southern blotting
of the gel, followed by probing of the mem-
brane with 32P-labelled oligomeric reporter
probe. The oligonucleotide reporter probe
used was for the amplified BamHl W region
of the EBV genome (1424-1439).
DNA extracted from Burkitt's lymphoid
cell line infected with EBV, Raji (ATCC,
Maryland, USA), was used as a positive con-
trol and DNA from rat spleen tissue sections
was used as a negative control.
On all samples negative for EBV DNA,
analysis using human ,B globin gene as an
internal control was performed by PCR
amplification followed by Southern blot.7
Sequences of oligonucleotide primers and probe used for the
amplification ofEBVDNA (5'- 3')
PrimerA: CCA GAG GTA AGT GGA CTT
(genomic location 1399-1417)
Primer B: GAC CGG TGC CTT CTlT AGG
(genomic location 1503-1520)
Probe: TTC TGC TAA GCC CAA C
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Figure 1 Results of the Southern blot hybridisation of the PCR products on s
carcinoma for the detection ofEBVDNA.
Results
Following amplification by F
Southern blot analysis of the
product, a weak signal for EBV
detected in only one of the eigh
vulval carcinoma cases (fig 1). EBV
detected in four out of the six co]
(fig 2). Positive results following an
of the fi globin gene was obtained
cases negative for EBV DNA.
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Figure 2 Results of the Southern blot hybridisation of the PCR products on
non-neoplastic vulval tissue for the detection ofEBVDNA.
Discussion
The role of viruses as aetiological agents in
carcinoma of the lower female genital tract
has been the focus of much interest but, to
date, the evidence has been inconclusive.
Researchers have postulated that two or more
viruses are necessary and that these might
interact at different states of carcinogenesis in
cervical carcinoma.3
A carcinogenic role for EBV in the female
genital tract has been suggested by the
demonstration of EBV (C3D) receptors in
normal cervical samples,5 8 and more recently,
EBV by the detection of EBV DNA in one out of
1 22b three smears, using PCR and subsequent122bp Southern blot, from patients with histolo-
gically confirmed epithelial abnormalities.9
The possibility has been raised that EBV
could be sexually transmitted.5 In the cervix
EBV replicates only in terminally differenti-
ated epithelial cells10 and this may account for
viral persistence without evident tissue
destruction. It is thought that cellular events
may be the decisive factor in determining
G lobinl whether the outcome is malignant transfor-
11 Obp mation or lytic infection.
Detection of EBV DNA in four out of sixvulval (66 6%) cases of non-neoplastic vulval
epithelium confirms the ubiquitous presence
of this virus. Such persistence of virus in
epithelial cells without serious destruction of
tissue or clinically apparent disease is a
?CR and feature of epithelial infection with other DNA
amplified viruses, such as cytomegalovirus (CMV) and
DNA was human papillomavirus (HPV).4 This mecha-
Lt cases of nism can provide a selfsustaining reservoir of
I DNA was infection in the lower female genital tract. A
introl cases similar study of cervical carcinoma done in
nplification our laboratory also showed a 44-5% inci-
I in all the dence of EBV DNA detected in normal cervi-
cal tissue compared with a similar 48-8%
incidence in cases of cervical carcinoma."1
Our study also showed, unusually, that
EBV DNA is rare in vulval carcinoma, sug-
gesting that EBV is probably not involved in
the development of vulval carcinoma. Such
findings are consistent with the observations
obtained from a local study on cervical carci-
nomall mentioned above. In that study the
prevalence of EBV DNA in the control group
of non-neoplastic cervical tissue and the
group of patients with invasive carcinoma of
the cervix was the same. The finding of a lack
of association between EBV and cancer of the
lower female genital tract in Hong Kong is
EBV significant and contrasts with the known
22bp strong association between EBV and
neoplasia in the upper respiratory tract
in Hong Kong-namely, nasopharyngeal
carcinoma.612 In situ hybridisation studies
were performed using an EBER 1 and 2
probe for anti-sense RNA, but they failed to
show any signal from any of the cases. The
EBV DNA detected by PCR in the four
control cases may have been below the
detection level of in situ hybridisation
G3lobin techniques.
110bp We conclude that EBV is not associated
with vulval carcinoma. Moreover, the detec-
tion of EBV in non-neoplastic vulval epithe-
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Epstein-Barr virus in carcinoma of the vulva
lium highlights its ubiquitous presence within
the lower female genital tract.
1 Arends MJ, Wyllie AH, Bird CC. Papillomaviruses and
human cancer. Hum Pathol 1990;21:686-98.
2 Hording U, Daugaard S, Iversen AKN, Knudsen J, Bock
JE, Norrild B. Gynecol Oncol 1991;42:22-6.
3 Zur Hausen H. Human genital cancer: synergism between
two virus infections or synergism between a virus infec-
tion and initiating events. Lancet 1982;ii:1370-2.
4 Young LS, Sixbey JW. Epstein-Barr virus and epithelial
cells: a possible role for the virus in the development of
cervical carcinoma. Cancer Surveys 1988;7:507-18.
5 Sixbey JW, Lemon SM, Oagano JS. A second site for EBV
shedding: the uterine cervix. Lancet 1986;ii:1 122-4.
6 Dickens P, Srivastava G, Loke SL, Chan CW, Liu YT.
Epstein-Barr virus DNA in nasopharyngeal carcinoma
from Chinese patients in Hong Kong. Clin Patol
1992;45:396-7.
7 Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplifica-
tion of 0-globin genomic sequences and restriction site
analysis for diagnosis of Sickle cell anaemia. Science
1985;230:1350-4.
8 Sixbey JW, Davis DS, Young LS, Hutt-Fletcher L,
Tedder TE, Rickinson AB. Human epithelial cell
expression of an EBV receptor. Gen Virol 1987;68:
805-11.
9 Bevan IS, Blonifield PI, Johnson MA, Woodman CBJ,
Young LS. Oncogenic viruses and cervical cancer.
Lancet 1989;i:907-8.
10 Sixbey JW, Davis DS, Young IS, Hutl-Fletcher L,
Tedder TF, Rickinson AB. Human epithelial cell
expression of an Epstein-Barr virus receptor. Clin Res
1986;34:533A.
11 Wong KY, Collins RJ, Srivastava G, Pittaluga S, Cheung
ANY, Wong LC. Epstein-Barr virus in carcinoma of the
cervix. IntJI Gynecol Pat/ol (in press).
12 Lung ML, Movahed LA, Butler AE, et al. In situ detec-
tion of Epstein-Barr virus markers in nasopharyngeal
carcinoma patients. Oncology 1989;46:310-7.
851
